Close Menu

NEW YORK – Integrated DNA Technologies and Chinese medical sequencing firm ChosenMed are jointly developing large pan-cancer gene panels as part of the Cancer Genome Atlas of China (CGAC) project, IDT said today.

Under the strategic collaboration, IDT, a unit of Danaher, will provide its next-generation sequencing enrichment products for cancer sequencing to Beijing-based ChosenMed and help to enhance the firm's R&D capabilities.

Financial details of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.